نتایج جستجو برای: tetanus antibody

تعداد نتایج: 173352  

Journal: :Infection and immunity 1999
S J Ward G Douce D Figueiredo G Dougan B W Wren

The C-terminal repeat domain of Clostridium difficile toxin A harbors toxin-neutralizing epitopes and is considered to be a candidate component of a vaccine against C. difficile-associated disease (CDAD). Fourteen of the 38 C-terminal toxin A repeats (14CDTA) were cloned into pTECH-1 in frame with the immunogenic fragment C of tetanus toxin (TETC) to generate plasmid p56TETC. Expression of the ...

Journal: :Bulletin of the World Health Organization 1997
V Dietz A Galazka F van Loon S Cochi

An estimated 400,000 deaths occur annually from neonatal tetanus (NT). In 1989 WHO adopted the goal of eliminating NT as a public health problem worldwide. To achieve this, and to control non-neonatal tetanus (non-NT), WHO recommends that newborns be passively protected at birth by the antepartum administration of at least two doses of tetanus toxoid (TT) to their mothers and that all children ...

2017
Iraj Golikhatir Seyed Hossein Montazer Nabiollah Bagheri Fatemeh Jahanian Farzad Bozorgi Seyed Mohammad Hosseininejad Hamed Amini Ahidashti

INTRODUCTION Based on the existing studies, measuring serum level of immunoglobulin for making decisions regarding prescription of tetanus prophylaxis seems logical and cost effective. Therefore, the present study was done with the aim of evaluating the diagnostic accuracy of tetanus quick stick (TQS) in comparison with ELISA method in this regard. METHODS The present diagnostic accuracy stud...

Journal: :The Journal of infectious diseases 1998
D J Fryauff S J Cryz H Widjaja E Mouzin L W Church M A Sutamihardja A L Richards B Subianto S L Hoffman

Immune suppression resulting from prolonged chemoprophylaxis and potential drug-vaccine interaction were investigated within the context of a randomized placebo-controlled trial that compared daily primaquine or weekly chloroquine administration for malaria prevention. After 11 months of prophylaxis, adult male subjects received a tetanus-diphtheria (Td) vaccination. Prophylaxis continued 4 wee...

2013
Jung-Woo Rhim Kyung-Yil Lee Sang-Yong Kim Jong-Hyun Kim Hyun-Hee Kim Hwang Min Kim Young-Youn Choi Sang-Hyuk Ma Dong-Ho Kim Dong Ho Ahn Jin-Han Kang

This phase II clinical trial was conducted to compare the immunogenicity and safety of a newly developed tetanus-reduced diphtheria (Td) vaccine (GC1107-T5.0 and GC1107-T7.5) and control vaccine. This study was also performed to select the proper dose of tetanus toxoid in the new Td vaccines. Healthy adolescents aged between 11 and 12 yr participated in this study. A total of 130 subjects (44 G...

Journal: :Iranian journal of immunology : IJI 2014
Mohsen Mohammadi Zahra Kianmehr Sussan Kaboudanian Ardestani Behnaz Gharegozlou

BACKGROUND Adjuvants are used to increase the immunogenicity of new generation vaccines, especially those based on recombinant proteins. Despite immunostimulatory properties, the use of bacterial lipopolysaccharide (LPS) as an adjuvant has been hampered due to its toxicity and pyrogenicity. Brucella abortus LPS is less toxic and has no pyrogenic properties compared to LPS from other gram negati...

Journal: :Journal of clinical microbiology 1991
J P Schröder W D Kuhlmann

Tetanus antitoxin in human sera was detected with solid-phase immunoassays in microtitration modules coated with tetanus toxoid by using Eu(3+)-labeled anti-human monoclonal antibodies on the basis of an exactly calibrated antibody standard. The use of a time-resolved fluorescence immunoassay (TR-FIA) significantly improved the quantitative detection of tetanus antitoxin over that of the enzyme...

Journal: :The New England journal of medicine 2007
Ian J Amanna Nichole E Carlson Mark K Slifka

BACKGROUND Maintenance of long-term antibody responses is critical for protective immunity against many pathogens. However, the duration of humoral immunity and the role played by memory B cells remain poorly defined. METHODS We performed a longitudinal analysis of antibody titers specific for viral antigens (vaccinia, measles, mumps, rubella, varicella-zoster virus, and Epstein-Barr virus) a...

Journal: :The Journal of clinical investigation 1986
M G Roncarolo J L Touraine J Banchereau

Fetal liver and thymus transplantation can be successfully employed for the treatment of severe combined immunodeficiency disease. In virtually all cases, donor and recipient cells are HLA mismatched. In a patient suffering from a severe combined immunodeficiency disease, full immunological reconstitution was obtained after fetal liver and thymus transplantation. HLA typing revealed that the pa...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید